Latest News

(UroToday.com) In this abstract at the 2021 European Association of Urology (EAU) annual meeting, Dr. Andrea Necchi presents the preliminary, feasibility results of the PURE-02 study, which assesses the use of pembrolizumab before radical nephroureterectomy in patients with high-risk Upper tract urothelial cancer (UTUC).

(UroToday.com) In the Upper Tract Urothelial Carcinoma: Molecular characterization and modern management session at the 2021 European Association of Urology (EAU) Annual Meeting, Gautier Marcq, and colleagues presented a novel classification system for upper tract urothelial carcinoma (UTUC) that may better risk stratify patients for kidney sparing strategies. Current EAU guidelines risk stratification upper tract […]

(UroToday.com) The game changing session of the European Association of Urology (EAU)’s 2021 annual meeting included a presentation by Dr. Michael Hofman from the Peter MacCallum Cancer Centre discussing the phase 2 trial of 177Lu-PSMA-617, TheraP, as well as important contrasts/differences between TheraP and VISION. TheraP was an ANZUP/PCFA sponsored trial that began in 2016 and represents […]

(UroToday.com) Dr. Nicolas Mottet,  the chair of this session “Guideline Session II: Prostate Cancer: cN+ in Newly Diagnosed Patients” provided an introduction and set the stage for the talks to follow. 

(UroToday.com) At the 2021 European Association of Urology (EAU) annual meeting, Dr. Ursula Vogl presented on immunotherapy for metastatic urothelial carcinoma as part of this thematic session on immuno-oncology (IO) therapy in urothelial cancer.

(UroToday.com) The 2021 European Association of Urology (EAU) annual meeting had a Controversies in Bladder Cancer 2021: Rapid-fire debates session. The session was introduced by Dr. Ashish Kamat with chairs of the session, Professors Joan Palou and Arnulf Stenzl. There were five rapid-fire debates with case-based discussions, multiple presenters have the opportunity to discuss nuances of common […]

(UroToday.com) Dr. Michiel S. Van Der Heijden focused the second talk of this thematic session at the 2021 European Association of Urology (EAU) annual meeting, on perioperative chemotherapy for muscle-invasive bladder cancer (MIBC).

(UroToday.com) The 2021 European Association of Urology (EAU) annual meeting had a Controversies in Bladder Cancer 2021: Rapid-fire debates session. The session was introduced by Dr. Ashish Kamat with chairs of the session, Professors Joan Palou and Arnulf Stenzl. There were five rapid-fire debates with case-based discussions, multiple presenters have the opportunity to discuss nuances of common […]

(UroToday.com) The 2021 European Association of Urology (EAU) annual meeting had a Controversies in Bladder Cancer 2021: Rapid-fire debates session. The session was introduced by Dr. Ashish Kamat with chairs of the session, Professors Joan Palou and Arnulf Stenzl. There were five rapid-fire debates with case-based discussions, multiple presenters have the opportunity to discuss nuances of common […]

(UroToday.com) Dr. J. Alfred Witjes kicked off the thematic session of immunotherapy in urothelial cancer with a talk on non-muscle invasive bladder cancer (NMIBC). Below I highlight his key points.